incretin mimetic agents glp 1 receptor agonists and insulin signaling as novel therapeutic targets for Alzheimer's and Parkinson's disease GLP-1 actions and target organs.

10.1016/j.jss.2019.07.017 10 BallardC.GauthierS.CorbettA.BrayneC.AarslandD.JonesE

BPC-157 modulates the nitric oxide system and suppresses specific inflammatory markers at the lesion site

Williams E et al

PLoS ONE 18(1):e0278685 Ferhatbegovi L, Mri D, Maci-Dankovi A (2023) The benefits of GLP1 receptors in cardiovascular diseases

Clinical trials did not include pregnant or breastfeeding women, children, elderly individuals over 65, or those with active malignancy or severe organ dysfunction

In vivo studies Regarding the effects of iodine excess on oxidative stress even more studies have been performed in in vivo conditions